Trademark Overview
On Sunday, October 19, 2025, a trademark application was filed for AMNIOGENX with the United States Patent and Trademark Office. The USPTO has given the AMNIOGENX trademark a serial number of 99450633. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Sunday, October 19, 2025. This trademark is owned by CellTherX Corp. The AMNIOGENX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Tissue-based products, namely, biological tissue grafts for use in dental, medical, and surgical procedures and applications; Pharmaceutical preparations and substances, namely, biological tissue grafts for use in regenerative medicine, wound repair, and surgical repair; Wound healing system, namely, biological tissue grafting materials for use in regenerative medicine, wound repair, and surgical repair; Biological tissue grafts used in combination with surgical implants for use in soft tissue reconstruction; Surgical implants made of biological materials for use in soft tissue
Surgical apparatus and instruments for medical and dental use; Surgical implants made of synthetic materials for use in soft tissue; Medical devices, namely templates for use in creating tissue grafts; Synthetic tissue grafting materials for use in dental, medical, and surgical procedures and applications; Pharmaceutical preparations and substances, namely, synthetic tissue grafting materials for use in regenerative medicine, wound repair, and surgical repair; Surgical sutures, namely, bioabsorbable surgical sutures